| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
FMG
|
17.70 | 54.4B | 11.28 | 1.90 | 5.18 | 21.0% | 10.9% | 73 | 67 | 29.13 | +48.4% | 92 | 0.27 |
|
BHP
|
67.30 | 342.1B | 24.94 | 4.96 | 8.26 | 37.8% | 10.6% | 60 | 61 | 56.64 | -11.9% | 89 | 0.55 |
|
NST
|
23.44 | 33.4B | 24.91 | 2.24 | 9.75 | 12.2% | 11.4% | 52 | 33 | 20.25 | -9.8% | 93 | 0.11 |
|
RIO
|
174.81 | 284.0B | 19.92 | 3.19 | 9.36 | 17.4% | 10.4% | 52 | 42 | 143.93 | -13.2% | 76 | 0.38 |
|
S32
|
5.16 | 23.1B | 75.87 | 1.75 | 12.11 | 8.9% | 11.1% | 46 | 30 | 3.83 | -18.6% | 80 | 0.18 |
|
MIN
|
64.63 | 12.7B | 100.00 | 3.59 | 17.54 | 7.1% | 10.9% | 36 | 52 | 48.39 | -18.1% | 46 | 1.51 |
|
EVN
|
14.88 | 30.4B | 72.04 | 7.34 | 22.45 | 14.6% | 11.2% | 35 | 30 | 4.88 | -50.4% | 75 | 0.49 |
|
IGO
|
8.69 | 6.6B | — | 3.14 | — | -20.7% | 12.7% | 35 | 17 | 7.44 | -6.9% | 84 | 0.02 |
|
PLS
|
5.40 | 17.4B | — | 4.93 | 227.44 | -0.7% | 11.5% | 26 | 28 | 2.28 | -32.4% | 66 | 0.19 |
|
LTR
|
1.23 | 3.9B | — | 6.71 | 3,428.31 | -13.7% | 10.7% | 10 | 8 | 0.40 | -33.9% | 21 | 1.43 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.